Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Naltrexone Initiation in Opioid Dependence
NCT02437344Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Jan 2015; status: completed.
02
Drugs
ketamine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02437344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437344.